{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:26:18Z","timestamp":1784154378491,"version":"3.55.0"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,9,27]]},"abstract":"<jats:sec><jats:title>Background and aims:<\/jats:title><jats:p>Cyclins and cyclin\u2010dependent kinase inhibitors play a crucial role in the control of cell cycle transitions. Enhanced expression of cyclin D2 and reduced expression of p27<jats:sup>kip1<\/jats:sup> (p27) have been implicated in the pathogenesis of cancer. Because intestinal metaplasia has been regarded as a pre\u2010malignant lesion, we investigated the expression of cyclin D2 and p27 in <jats:italic>Helicobacter pylori<\/jats:italic>\u2010associated chronic gastritis with and without intestinal metaplasia, and followed the changes after <jats:italic>H. pylori<\/jats:italic> eradication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Expression of cyclin D2 and p27 was studied by immunohistochemistry in 59 patients (including 35 patients with intestinal metaplasia) and in 10 gastric cancer patients. Among them, 29 <jats:italic>H. pylori<\/jats:italic>\u2010infected patients had serial gastric biopsies taken before and at 1\u2010year after eradication of <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Expression of cyclin D2 was significantly higher in gastric cancers when compared to their adjacent non\u2010tumour tissues (median score 3 vs. 1, <jats:italic>P<\/jats:italic>=0.015). Over\u2010expression of cyclin D2 was detected in <jats:italic>H. pylori<\/jats:italic>\u2010associated chronic gastritis and intestinal metaplasia, which was reduced after eradication of the organism (median score 2 vs. 1, <jats:italic>P<\/jats:italic>=0.037 in chronic gastritis; median score 2 vs. 0, <jats:italic>P<\/jats:italic>=0.008 in intestinal metaplasia). While the normal gastric mucosa showed strong p27 expression, five of the 10 gastric cancer tissues exhibited reduced p27 expression (<jats:italic>P<\/jats:italic>=0.039). Diminished p27 expression was also seen in intestinal metaplasia, which was restored 1\u2010year after <jats:italic>H. pylori<\/jats:italic> eradication (eight out of 16 vs. one out of 16, <jats:italic>P<\/jats:italic>=0.018). Reduced expression of p27 was frequently associated with increased cyclin D2 expression in <jats:italic>H. pylori<\/jats:italic>\u2010associated intestinal metaplasia (<jats:italic>P<\/jats:italic>=0.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Over\u2010expression of cyclin D2 and reduced expression of p27 are closely linked to <jats:italic>H. pylori<\/jats:italic>\u2010associated intestinal metaplasia. Eradication of <jats:italic>H. pylori<\/jats:italic> infection reverses the aberrant expression of cyclin D2 and p27 in intestinal metaplasia.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2001.01038.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:45:08Z","timestamp":1047354308000},"page":"1505-1511","source":"Crossref","is-referenced-by-count":36,"title":["Effect of <i>Helicobacter pylori<\/i> eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia"],"prefix":"10.1111","volume":"15","author":[{"given":"J.","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K. W.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. F.","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P. A.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Y. Y.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. K. L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C. S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J. Y.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"307","article-title":"Molecular biological observations in gastric cancer","volume":"23","author":"Tahara E","year":"1996","journal-title":"Semin Oncol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90126-D"},{"key":"e_1_2_6_4_2","first-page":"285","article-title":"Expression of cyclins D1 and E in human colon adenocarcinomas","volume":"28","author":"Sutter T","year":"1997","journal-title":"J Med"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004320050309"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-9098(199907)71:3<147::aid-jso3>3.3.co;2-x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64763-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4652(200004)183:1<18::aid-jcp3>3.3.co;2-j"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81237-4"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-227"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-222"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0297-231"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1997.tb00428.x"},{"key":"e_1_2_6_14_2","unstructured":"IARC Working group on the Evaluation of Carcinogenic Risks to Humans.Helicobacter pylori. In: Schistosomes Liver Flukes andHelicobacter Pylori: Views and Expert Opinions of an IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Lyon: IARC 1994: 177\u2013240."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19990517)81:4<543::aid-ijc7>3.0.co;2-3"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.1.19"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.5321-5328.2000"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(20000115)85:2<192::aid-ijc8>3.3.co;2-6"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012070-00001"},{"key":"e_1_2_6_21_2","first-page":"236","article-title":"A follow\u2010up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori","volume":"3","author":"Satoh K","year":"1998","journal-title":"Helicobacter"},{"key":"e_1_2_6_22_2","first-page":"115","article-title":"Helicobacter pylori eradication and antral intestinal metaplasia\u2014two years follow\u2010up study","volume":"48","author":"Ciok J","year":"1997","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.8550"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.23.1881"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01038.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01038.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.01038.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:25:40Z","timestamp":1695828340000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.01038.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,27]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9,27]]}},"alternative-id":["10.1046\/j.1365-2036.2001.01038.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01038.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,27]]}}}